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COMPARISON OF STA TED IRON CONCENTRATIONS BETWEEN NAME 
BRAND AND GENERIC CHILDREN'S MULTIVITAMINS 
by Ashlea Nicole Pettengill 
May 2013 
The mineral iron is one of the most common minerals on Earth; not only is iron 
found in the atmosphere, water, and plants, it is an essential mineral needed for the 
human body. Children need iron at a young age to ensure proper growth and development 
of myelin, to promote oxygen transportation within red blood cells, and to assist in 
Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA). With iron readily available 
in children's multivitamins, iron toxicity can become an issue when taking too many 
tablets. With two types of brands, generic and name brand, parents should be aware of the 
quality,-along with quantity, of the iron concentrations of the vitamins. 
This experiment focused on comparing the observed iron concentrations with the 
expected iron concentrations between generic and name brand children's multivitamins. 
All samples were diluted equally and analyzed with a graphite furnace atomic absorption 
spectrometer. 
Comparison of the correlation of relative variation (CRV) shows that within each 
specific brand, name brand vitamins had less variation and, thus, more precise iron 
concentrations than the generic brand vitamins, which showed iron concentrations within 
each generic brand multivitamin to be greatly varied. Comparison of the difference of 
means (mg) shows that the observed iron concentrations for name brand children's 
11 
multivitamins were very close to the expected iron concentration, which expresses 
accuracy for the name brand children' s multivitamins, while generic brand multivitamins 
had a large difference of means resulting in generic brands showing 4-6 milligrams of 
iron less than what was expected per tablet. 
lll 
ACKNOWLEDGMENTS 
I would like to thank the thesis director, Dr. Thomas Pittman, and the other 
committee members, Dr. Dean Bertram and Dr. Kuppareddi Balamuragan, for their 
advice, patienc~, and support throughout the duration of this project. I would especially 
like to thank Dr. Thomas Pittman for his guidance throughout the process and having 
confidence in me when I was not confident in myself. Without my committee members' 
guidance, I would not have been able to complete this project. 
I would also like to thank the other faculty members at the School of Criminal 
Justice, whose support and advice was greatly appreciated. Many thanks also go to my 
mother and my coworkers, who equally supported me throughout this process. 
lV 
TABLE OF CONTENTS 
ABSTRACT .................................. . ...... . ..... . ...... . ... . ........ . ....................... ii 
ACKNOWLEDGMENTS .. . . . ..................................................................... iv 
LIST OF TABLES ................................................... . . . .... . .. .. ... ... ... . .. . .. ..... vi 
LIST OF ILLUSTRATIONS ...................... . ....... ... ......... . ............... . ........... vii 
CHAPTER 
I. INTRODUCTION .................. ... ...... . .. ... ...... . . . ........... . ........... 1 
II. RE\TIEW OF LITERATURE ....... . ....... ... . . .... . .. ............... . ......... 4 
Iron and its Role in the Human Body 
Iron and its Connection with Multivitamins 
lron Poisonings Through Multivitamins 
Graphite Furnace Atomic Absorption Spectroscopy 
III. METHOD AND MATERIALS .................................................. 14 
Procedure 
I\l. DATA AND RESULTS ......................................................... 23 
\l. DISCUSSION .......... .. .. . ....... . .... .. .......... . . . ...... . . . .... . ...... . . . .... 33 
AP.PEND IX ..... . ...... . . . ... ... ...... . . . ...... .. .... . . . ................. . ............... . . . ..... .... 3:5 
REFERENCES ..................................................................................... 37 
V 
LIST OF TABLES 
Table 
1. Standards oflron Concentrations and Absorbance Values ............... ........... .......... 25 
2. Name brand A's Iron Concentrations ............................. ........... ................. ........... 25 
3. Name brand B's Iron Concentrations ...... ... ........................... ... .. .......... .............. ... 26 
4. Name brand C' s Iron Concentrations ................. ... ............... ............ ... ........... ....... 27 
5. Name brand D' s Iron Concentrations .. ........... ... ..................... ...... .................... ... .. 27 
6. Generic E' s Iron Concentrations ... .............. ... ............ .. ................ .. .......... .............. 28 
7. Generic F's Iron Concentrations .. .. ......... ... ................................. .............. ... .......... 29 
8. Generic G' s Iron Concentrations ...... ................. ... ............ ... .. ....... ... ...................... 30 
9. Generic H's Iron Concentrations ........ ........... ... ....... ... .................... .. .......... ........... 30 
10. Comparison of All Brands' Descriptive Statistics ........ ... ...... ..... .... .. ... ............ ... ... 32 
VI 
LIST OF ILLUSTRATIONS 
Figure 





Iron is the most abundant metal forming the Earth's crust and core, and it is the 
most common element by mass in the Earth' s crust (Fine, 2000). Iron can also be found 
in the atmosphere, water, and plants. Not only does iron play a crucial role in the 
environment, but it also plays an essential part in the human body. Iron contributes to 
numerous enzymatic mechanisms and biochemical processes of the body. Lieu, Heiskala, 
Peterson, and Yang (2001) state that iron plays a key part in Deoxyribonucleic acid 
(DNA) and Ribonucleic acid (RNA) synthesis, cellular growth, cell differentiation, 
memory strength, oxygen transportation from lungs to tissues and muscles, and new red 
blood cell creation. Iron is essential to life. 
There are medical conditions, however, that arise from levels of body iron stores 
being insufficient or, conversely, overly abundant. The lack of iron amounts in the body 
is a medical condition known as anemia; anemia is one of most common iron disorders in 
humans and is the most common form of malnutrition (Finkelstein et al. , 2007). Slight 
iron deficiency's symptoms include increased fatigue, increased forgetfulness, and a low 
red blood cell count; these symptoms can usually be remedied by taking multivitamins 
containing iron daily and eating a healthy iron-rich diet (National Institutes of Health 
[NIH], 2007). A severe deficiency of iron can hinder a person's cellular growth and 
brain development and can lead to cellular damage and death (Lieu et al., 2001). 
Symptoms from iron toxicity can range from vomiting and diarrhea to organ failure 
(Balmadrid & Bono, 2009). 
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A common way to help children and adults boost their levels of iron to maintain 
the healthy, regulated amount is by taking multivitamins enriched with iron. It was 
reported that between 1999 and 2000, approximately 52% of adults stated that they had 
taken a dietary supplement, and 32% of adults shared they take a multivitamin daily 
(Rock, 2007). For children, usage of multivitamins containing elemental iron was more 
than 30%; the majority of the children taking multivitamins was between one and eight 
years old (Picciano et al., 2007). Since the 1930s pediatricians have recommended the use 
of multivitamin supplements to children to help ward off deficiencies (Picciano et al., 
2007). According to Pestaner et al. ( 1999) ferrous sulfate, the iron found in 
multivitamins, is among "the cheapest...most frequently used iron supplement and has an 
elemental iron content of approximately 20%" (p. 192). Iron supplements have become 
readily accessible without a prescription and, therefore, parents buy them to help their 
child's growth. Children enjoy the multivitamins because of the variety of flavors, the 
likeness to particular cartoon characters or animals, and the resemblance of multivitamins 
to candies. 
Iron poisoning through multivitamins is the most common and potentially serious 
poisoning among children (Pestaner et al., 1999). Severity of iron ingestion starts at 
approximately 20 milligrams per kilogram and fatal dose amount is approximately 180 
milligrams per kilogram (Sipahi, Karakurt, Bakirtas, & Tavil, 2002). Accidental iron 
poisonings occur from ingesting an excess amount of multivitamins with elemental iron 
because children ingest the supplements as candy. According to Anderson, Turchen, 
Manoguerra, & Clark (2000), numerous case reports of iron poisoning, both serious and 
fatal, have been documented. Ages for iron poisonings range from infants to preschool 
children. Iron poisonings, for the most part, are accidental but there have been few 
reports of intentional iron poisoning of a child (Child Abuse, 2003). 
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Testing for metals in many substances requires specialized instrumentation. The 
graphite furnace atomic absorption spectrometer is often used. Graphite furnace atomic 
absorption is a method used around the world to test for metals in almost every scientific 
field. Since its earliest use in analytical chemistry in the 1960s, scientists have used the 
basic principle of graphite furnace atomic absorption to build similar instruments with 
unique characteristics. Due to the sensitivity, specificity, and need for only small sample 
amounts, many scientists use the instrument to run samples of unknown concentration of 
metals in many government laboratories, as well as in university laboratories. The 
versatile nature of the instrument has spread through all types of sciences including 
biology, chemistry, clinical, and environmental. 
This study was conducted to analyze various children' s multivitamins, both 
generic and name brand, that are enriched with elemental iron and to compare the iron 
concentrations stated on the labels with the actual concentration found using the graphite 
furnace atomic absorption spectrometer. The null hypothesis is that the iron 
concentrations in each multivitamin will not be equivalent to the iron concentrations 
stated on the specific multivitamin' s label. 
CHAPTER II 
REVIEW OF LITERATURE 
Iron and its Role in the Human Body 
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Iron is an essential mineral for the human body and is required for most living 
organisms. It contributes to a variety of physiological and biochemical processes. One 
important function of iron is assisting with oxygen transportation in the human body. 
Lieu et al. (2001) states that approximately 60% of iron in the human body is located in 
the protein hemoglobin. Ferric iron describes the iron specifically located within the 
hemoglobin and the oxygen transporting processing, which is responsible for transporting 
oxygen via red blood cells from the lungs to the numerous tissues of the body. The 
formation of blood cells to help transfer oxygen requires iron daily (Miret, Simpson, & 
McKie, 2003). The majority of the remaining iron helps transport oxygen to the muscles 
throughout the body and ensures the biochemical mechanisms of the muscles are 
regulated through the protein myoglobin (NIH, 2007). 
Along with oxygen transportation, iron also has crucial roles with other 
mechanisms of the body. Iron contributes to the cell proliferation and differentiation. 
Three genes needed for transcription, the progress of cell cycling, and cell differentiation 
all rely on iron being present; without iron, cells in the body would not be able to 
progress in growth and eventually differ from one another's processes (Lieu et al., 2001). 
Iron also helps with Deoxyribonucleic acid (DNA) synthesis and Ribonucleic acid (RNA) 
synthesis by being a key factor for enzymes needed for the synthesis processes, such as 
oxidases, peroixdases, and aconitases (Lieu et al., 2001 ). If iron is not being used for 
hemoglobin, myoglobin, or components needed for cell processes and syntheses, it is 
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stored in the body as ferritins (Fine, 2000). Ferritins make up approximately one-third of 
iron in the body (Fine, 2000). When needed, stored iron is transported to the bone 
marrow where hemoglobin is synthesized from the iron located in the plasma and the 
recycled iron from dead red blood cells. Iron also plays a part in electron transportation, 
due to being able to accept and donate electrons, and in the production of myelin, which 
plays a crucial role in normal brain functions, such as memory (Lieu et al., 2001 ). 
According to the National Institutes of Health (2007), recommended daily allowances for 
infants to one year olds should be approximately 11 milligrams per kilogram; one to three 
year olds require approximately seven milligrams per kilogram; four to eight year olds 
should take 10 milligrams per kilqgram of iron daily. 
Because iron plays such a key part in human life, it is very important to ensure 
that iron levels are regulated at proper levels. Problems with iron production can range 
from a lack of iron throughout the body to having excessive amounts of iron in the body, 
resulting in iron overload. Iron disorders can be fatal and are very common. Gurzau, 
Neagu, and Gurazu (2003) states that "disorders of iron metabolism are among the most 
common diseases of humans, encompassing a broad spectrum of diseases ... ranging from 
anemia to iron overload" (p. 193). The lack of iron present in the body is a medical 
condition known as anemia. Anemia due to lack of iron is very common and is most 
diagnosed out of all iron metabolism disorders (Lieu et al. , 2001 ). Finkelstein et al. 
(2007) states that iron deficiency anemia "affects more than two billion people globally" 
(p. 414). According to Christine Swanson (2003), iron deficiency anemia is "the most 
common nutritional deficiency" (p. 100). Lieu et al. (2001) explains that iron anemia is 
attributed to low iron absorption from not maintaining a healthy diet that contains food 
with the proper amounts of iron, blood loss from diseases or trauma, unusually high pH 
in the gastrointestinal region of the body, and/or dysfunction ofred blood cells. Iron 
deficiency causes a loss of oxygen transported from lungs to muscles and tissues, 
resulting in increased fatigue and forgetfulness (NIH, 2007). 
On the other end of the spectrum for iron-related diseases is iron overload, also 
known as iron toxicity. Iron toxicity occurs naturally due to the body's process to 
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regulate free radicals of iron by chelating the iron during its absorption and distribution 
phases (Fine, 2000). The easily accepting iron molecule reacts with free radicals, such as 
superoxide, and byproducts of hydrogen peroxide to form more free radicals that are 
potentially more hazardous; when iron interacts with the byproducts of hydrogen 
peroxide, the hydroxyl radical is formed and can cause DNA strands to break, cause 
enzymes to become inactive, and promote cell damage or death (Fine, 2000). Iron 
overload can transpire when there is iron excess from an outside source, like vitamins or 
blood transfusions with anemia, which is called transfusional siderosis (Gurzau et al., 
2003). According to Carlsson, Cortes, Jepson, and Kanstrup (2007) the four stages of iron 
toxicity are "local corrosive stage .. .latent asymptomatic phase ... organ failure (including 
hepatic, cardiac, pulmonary, and renal failure), and gastrointestinal scarring" (p. 321). 
Iron toxicity' s effects range from vomiting and abdominal pain to long-term problems, 
such as brain damage and possibly cancer (Balmadrid & Bono, 2009; Gurzau et al., 
2003). 
Iron and its Connection with Multivitamins 
Multivitamins can be taken to help an individual suffering from iron deficiency 
but may also help increase the chances of iron toxicity if the intake of iron is not carefully 
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monitored. While multivitamin-mineral supplements have no set definition, John Segan 
(2006) defines multivitamins in McGraw-Hill Concise Dictionary of Modern lvfedicine as 
"an often self-prescribed OTC [over the counter] diet supplement containing lipid-soluble 
vitamins-A, D, E, K; water-soluble vitamins- thiamin- vitamin B1, riboflavin- vitamin B2, 
vitamin B6, vitamin B12, vitamin C, folic acid, niacin, pantothenic acid, biotin; minerals-
calcium, phosphorus, iron, iodine, magnesium, manganese, copper, zinc" (p. 434). 
Multivitamins can help regulate levels of vitamins and minerals present in a person 
suffering from a mineral or vitamin deficiency. Swanson (2003) states that "multivitamin 
and mineral supplements, most containing iron as ferrous sulfate, are consistently the 
most widely used dietary supplement products" (p. 101 ) . One of the main reasons it is 
one of the most widely used supplements is because iron can be purchased either with a 
prescription or over the counter (Kennedy, 2007). Between the years of 1999 and 2000, a 
survey reported that 47% of men and 57% of women used an iron-containing supplement 
within the past month (Picciano et al., 2007). In the same survey, 31 .8% of children were 
given supplements containing iron; within the 31.8% of children recorded, ages of less· . 
than one year to eight years resulted in the most usage of multivitamins at 60.4% 
(Picciano et al., 2007). The survey also showed that out of all supplements taken 
multivitamins were used most often among children (Picciano et al. , 2007). Children 
typically need more iron than adults because iron is needed for brain development and 
cellular growth, so parents are more prone to giving their young child multivitamins 
daily. Children's chewable multivitamins generally contain approximately 18 milligrams 
of elemental iron or less (Manoguerra et al., 2005). Nowadays, children's multivitamins 
can come in an array of options. Common types of multivitamins for children include 
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gummies, fruit-flavored chewable tablets, and powders to dissolve in water to drink. 
Children do not mind taking multivitamins because the taste appeals to them and 
marketers relate to the children by making the multivitamins into cartoon characters. This 
poses potential problems for parents who fail to secure the multivitamins from young 
children because children are very adaptive and will seek out the sweet multivitamins 
when not supervised by the parents. 
Iron Poisonings Through Multivitamins 
While multivitamin supplements containing iron can help those who have a 
deficiency, taking large doses can cause an excess amount in the body and can result in 
fatal consequences. Iron then becomes a poison. A poison, according to the Encyclopedia 
Britannica Online, is defined as "any substance (natural or synthetic) that, at a certain 
dosage, damages living tissues and injures or kills" (p. 1). Poison by iron occurs when a 
person ingests an excess of iron. For doses of iron to be toxic for children, he or she must 
ingest approximately 40 milligrams of ferrous iron per kilogram of body weight; for 
doses of iron to be fatal, approximately 100 milligrams of ferrous iron per kilogram of 
body weight needs to be ingested (Carlsson et al., 2007). According to Fine (2000), iron-
poisoning cases were first published in the 1940s and the 1950s. While adults are 
susceptible to iron poisonings from vitamins containing iron, iron poisoning is more 
common among young children due to their smaller body weight. Finkelstein et al. 
(2007) believes that another reason overdosing on iron for children is more common is 
because iron products, such as prenatal vitamins and multivitamins containing iron, are 
easy to obtain and have a widespread availability. 
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Pestaner et al. (1999) testifies that "iron-containing products are the leading cause 
of accidental pediatric poisonings" (p. 192). Sipahi, Karakurt, Bakirtas, and Tavil (2002) 
states the following about iron poisoning statistics: 
Iron containing drugs have become more available in many households, 
leading to an increase in iron poisoning during childhood. Iron related 
injuries increased 150% in the USA from an annual average of 1200 in 
1980 to 3000 in 1996. About one third of injuries from 1980 through 1996 
involved infants under 2 years and one third involved 3 to 4 years (p. 948). 
Manoguerra et al. (2005) states that one case report where a two year old that ingested 
780 milligrams of iron in the form of a multivitamin did not die but suffered with 
gastrointestinal problems. Iron poisoning is the leading cause of death in children 
(Juurlink, Tenenbein, Koren, & Redelmeier, 2003). In 1987, a survey was conducted and 
described that 14,209 poison exposures of iron supplements had been reported and that 
66% of the exposures were from children ingesting chewable multivitamins (Everson, 
Oudjhane, Young, & Krenzelok, 1989). Ling, Hornfeldt, and Winter (1991) states that '.'in 
1988, there was 15,977 exposures to iron-fortified vitamin tablets. Of these, 10,475 or 
65.6% were children's formulations" (p. 25). Morse et al. (1997) stated that " in 1995 
alone, more than 22,000 children accidentally received [from parents, other family 
members, and/or babysitters] vitamins containing iron" (p. 1043). In 2003, 24,847 
preschool children were admitted to a hospital for excess multivitamin ingestion of iron, 
causing an overdose (Finkelstein et al., 2007). In 2007, a case was reported of an 18 
month old infant ingesting several multivitamins containing iron and developing 
persistent metabolic acidosis with a positive anion gap (Carlsson et al., 2007). Sipahi et 
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al. (2002) records five cases in which children, all under the age of five, were admitted to 
the hospital for accidental iron poisoning; each child had ingested over 20 milligrams per 
kilogram of elemental iron and were treated for iron toxicity. In 1972, two children aged 
two and three were admitted to the hospital for ingesting approximately 42 tablets of 
iron-containing chewable multivitamins; between the two siblings, they had ingested 504 
milligrams of elemental iron and were in acidosis (Viets, Bilodeau, & Langstaff, 1974). 
In 1973, two siblings, ages two and four, shared 80 iron-fortified chewable multivitamins, 
ingesting approximately 960 milligrams of elemental iron; the two siblings were sent to 
the hospital being acidotic and were treated for iron poisoning (Viets et al., 1974). In 
2007, 459 incidental iron poisoning in children cases were reported in Illinois alone; from 
the 459 cases reported, 429 children (93.7%) ingested multivitamins containing iron, and 
multivitamins in tablet or gummy form were taken by 427 children (94.9%) (Finkelstein 
et al., 2007). 
Iron poisoning in children can lead to death if enough iron is ingested. A national 
survey recorded that between 1983 and 2000, 43 children died from ingesting an excess. 
of iron through supplements (Manoguerra et al., 2005). From June 1992 to January 1993, 
the Center for Disease Control reported that five toddlers, all under the age of two years, 
died from ingesting iron supplements; the children, who were all unrelated, ingested 
numerous vitamins that they believed were candy (Weiss, Alkon, Weindlar, Kelter, & 
Delacruz, 1993). Although most cases reported of iron toxicity in children are accidental, 
intentional poisonings have also been reported. Intentional poisonings, the few that are 
reported, are a form of child abuse. One case report discusses that a 15 year old mother 
attempted to kill her seven week old infant by giving the child a minuscule amount of 
Formula 409 and crushing several iron-containing tablets to feed to him (Child Abuse, 
2003). While deaths through multivitamins are diminishing slightly, there are still 
concerns about children ingesting too many multivitamins. 
Graphite Furnace Atomic Absorption Spectroscopy 
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Scientists can use the graphite furnace atomic absorption spectrometer to 
determine the concentration of metals and/or metalloids that are present in a particular 
sample. The main purpose of graphite furnace atomic absorption spectroscopy, as a 
whole, is to test for particular metals and metalloids in a sample using an electrothermal 
atomizer as an energy source. Though graphite furnace atomic absorption has been 
around for many years, the application of using it for chemical analyses did not happen 
until 1956, (L'Vov, 1997). L'Vov states that Alan Walsh's paper "marked the official 
birth of a new method of instrumental analysis: atomic absorption spectrometry (AAS)" 
(L'Vov, 2004, p. 382) Since 1956, graphite furnace atomic absorption spectroscopy 
became very important within the discipline of clinical chemistry. During the 1960s 
electrothermal atomic absorption spectroscopy really began to interest the clinical 
chemistry world, with scientists and doctors alike using the instrument to do direct 
analyses of trace metals in biological fluids and high-solubility solids (L' Vov, 1997). The 
graphite furnace atomic absorption spectrometer is a relatively simple instrument with 
few components. The components of the graphite furnace atomic absorption spectrometer 
are a graphite tube, the furnace, a light source, an inert gas, detector, signal display, and 
data station. The basic idea behind graphite furnace atomic absorption is that a very small 
amount of the sample being tested is injected into the graphite tube; the furnace then, 
through a series of steps, is brought to an extremely high temperature that causes an 
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atomic cloud to form within the tube. The beam from the light source shines through and 
absorption of the specific analyte is recorded (Kenkel, 2010). How the specific 
wavelengths are chosen to absorb the atoms in the sample is determined by what 
metal/metalloid is specifically being tested for. The inert gas, usually argon, travels inside 
and outside of the graphite tube to help protect the tube and the furnace itself from the 
high temperatures as well as remove any remaining analyte between analyses. 
Temperatures required within the furnace to atomize metals can reach as high as 3200°C. 
There are advantages and disadvantages to using graphite furnace atomic 
absorption spectroscopy methods. One important advantage of this instrument is it is 
known to be one of the most sensitive and most precise instruments for metal analysis 
(Schlemmer & Radziuk, 1999). The graphite furnace atomic absorption method is also 
recognized for its ability to get such accurate readings with such a small amount of 
sample, usually between five and 15 microliters (Schlemmer & Radziuk, 1999). Another 
advantage of the graphite furnace atomic absorption instrument is that the _entire process 
is automatic, thus giving scientists the ability to accomplish other tasks while samples are 
being analyzed. 
With advantages, however, come disadvantages for the graphite furnace atomic 
absorption spectrometer. One disadvantage is, because the graphite furnace atomic 
absorption spectrometer is so sensitive, the samples niay have to be diluted several times 
for the instrument to get an accurate reading. Samples that are too concentrated can 
overload the lamp and the instrument, resulting in carryover and contamination. Another 
disadvantage is that interferences from the sample are much more common with the 
graphite furnace atomic absorption spectrometer; according to John Kenkel ~ O 10), 
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author of Analytical Chemistry for Technicians Third Edition, " interferences (background 
absorptions) are more common and more severe" (p. 261 ). Kenkel (2010) also states that 
the readings produced by the graphite furnace atomic absorption spectrometer cannot be 
reproduced as easily due to the instrumentation's setup. 
/ 
CHAPTER III 
METHODS AND MATERIALS 
Procedure 
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Various brands of children' s multivitamins, both name brand and generic, were 
bought and collected for analysis of iron concentration. The vitamins were then ground 
with a mortar and pestle to a fine powder that can be easily dissolved in the organic 
solvent. Once each tablet was weighed, one-eighth of the tablet was separated and 
weighed for confirmation. The one-eighth sample of each tablet was then treated with 
0.2% nitric acid. The samples were then vortexed until mixed completely, and then 
centrifuged for 3,000 rpm for 40 minutes for separation of layers. After being 
centrifuged, samples had a top, thin layer of the crushed tablet; this small layer was 
aspirated off the liquid layer to decrease chances of the tablet grains being present. Then 
10.00 µL of each sample was placed in new, separate test tubes; 10.00 mL of 0.253 mg/g 
magnesium nitrate matrix modifier was then added to each test tube. The samples were 
vortexed. Then, in new, separate test tubes, 1.00 mL of the 0.253 mg/g magnesium nitrat~ 
matrix modifier was added along with 1.00 mL of the previous samples created. The new 
samples were then vortexed and were analyzed with the graphite furnace atomic 
absorption spectrometer. 
Preparation of 2% Nitric Acid (HN03) Solution 
The 2% nitric acid solution used was made from 100% nitric acid (Fischer 
Scientific, Houston, TX) and Type III water (Milli-Q A 10, Billerica, MA). The solution 
was made as follows: 
1. 450.00 mL of Type III water was measured ot.t and placed in a 500 mL 
Erlenmeyer flask. 
2. 10.00 mL nitric acid (Fisher Scientific) was measured out and placed in the 
500 mL Erlenmeyer flask containing the 450.00 mL of Type III water. 
3. 40.00 mL of Type III water was added to the 500 mL Erlenmeyer flask for a 
final volume of 500.00 mL of 2% nitric acid solution. 
Preparation of0.253 mglg Magnesium Nitrate (Mg(N03)2) Matrix Modifier Solution 
The 0.253 mg/g magnesium nitrate solution used was made using metal free 
magnesium nitrate (Fischer Scientific, Houston, TX) and Type III water (Milli-Q AlO, 
Billerica, MA). The solution was made as follows: 
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1. 900 mL of Type III water was measured and placed in a 1,000 mL Erlenmeyer 
flask. 
2. 0.253 g of magnesium nitrate (Fisher Scientific) was weighed and placed in 
the 1,000 mL Erlenmeyer flask containing 900.00 mL of Type III water. 
3. 100.00 mL of Type III water was added to the 1,000 mL Erlenmeyer flask for 
a final volume to 1,000 mL of 0.253 mg/g magnesium nitrate solution. 
Preparation of Iron Standards 
Standards of iron in concentrations of 0.010, 0.025, 0.050, 0.100, and 0.250 mg/g 
were prepared to produce a calibration curve for quantitation purposes. This was 
completed through the following steps: 
1. A standard stock of 1,000 µg/rriL iron was obtained (PerkinElmer, Shelton, 
-........__ 
CT) and 0.1 mL of the 1,000 µg/mL stock standard was added to 9.9 mL 2% 
nitric acid for a concentration of 0.010 mg/g. 
2. 0.25 mL of the 1,000 µg/mL stock standard was placed in a new tube with 
9.75 mL 2% nitric acid for a concentration of 0.025 mg/g. 
3. 0.50 mL of the 1,000 µg/mL stock standard was placed in a new tube with 
9.50 mL 2% nitric acid for a concentration of 0.050 mg/g. 
16 
4. 1.0 mL of the 1,000 µg/mL stock standard was placed into a new tube with 9 .0 
mL 2% nitric acid for a concentration of 0.100 mg/g. 
5. 2.5 mL of the 1,000 µg/mL stock standard was placed into a new tube with 7.5 
mL 2% nitric acid for a concentration of 0.250 mg/g. 
6. Each standard was vortexed on highest speed for approximately five to seven 
seconds to ensure complete mixture. 
7. 10 µL of the 0.010 mg/g standard was placed in a new test tube and 10.00 mL 
of magnesium nitrate matrix modifier solution was also added. 
8. 10 µL of the 0.025 mg/g standard was placed in a new test tube and 10.00 mL 
of magnesium nitrate matrix modifier solution was also added. 
9. 10 µL of the 0.050 mg/g standard was placed in a new test tube and 10.00 mI: 
of magnesium nitrate matrix modifier solution was also added. 
10. 10 µL of the 0.100 mg/g standard was placed in a new test tube and 10.00 mL 
of magnesium nitrate matrix modifier solution was also added. 
11. 10 µL of the 0.250 mg/g standard was placed in a new test tube and 10.00 mL 
of magnesium nitrate matrix modifier solution was also added. 
12. Each diluted standard was then vortexed to ensure proper mixture of solutions. 
13. 1.0 mL of each standard was then placed in a new, separate test tubes. 
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14. 1.0 m!-, of the magnesium nitrate matrix modifier was added to each test tube 
containing 1.0 mL of standard. 
15. Each standard was then vortexed. 
Preparation of0.2% Nitric Acid (HN03) Solution 
The 0.2% nitric acid solution used was made from original 2% nitric acid solution 
prepared in the previous step and Type III water. The solution was prepared by the 
following steps: 
1. 450.00 mL of Type III water was measured out and placed in a 500 mL 
Erlenmeyer flask. 
2. 10.00 mL nitric acid (Fisher Scientific, Houston, TX) was measured out and 
placed in the 500 mL Erlenmeyer flask containing the 450.00 mL of Type III 
water. 
Sample Preparation for Analysis 
The following steps accomplished the preparation for the samples analyzed 
through the graphite furnace atomic absorption spectrometer (AAnalyst 800, Perkin 
Elmer, Shelton, CT): 
1. Each sample was randomly selected from its specific brand. 
2. Each tablet was then weighed out using the analytical scale 
3. Each tablet was then crushed using a mortar and pestle. 
4. Each tablet then had one-eighth of the mass measured out and placed in 
separate test tubes. 
5. 10.0 mL .2% nitric acid was added to each test tube containing a vitamin. 
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6. The standards and sample tubes were capped and vortexed until sample was 
mixed completely. 
7. The standards and sample tubes were centrifuged at 3,000 rpm for 40 minutes. 
8. The samples then had the top layer of leftover tablet grains aspirated. 
9. 10.00 µL of each sample was placed in separate, new test tubes. 
10. 10.00 mL of 0.253 mg/g magnesium nitrate matrix modifier was then added to 
each test tube containing 10.00 µL of sample. 
11. Samples were then capped and vortexed for proper mixture. 
12. After being vortexed, 1.00 mL of each sample was then placed in new, 
separate test tubes. 
13. To each test tube with 1.00 mL of sample, 1 mL of0.253 mg/g magnesium 
nitrate matrix modifier was added. 
14. Samples were then capped and vortexed to ensure complete mixture. 
15. The standards and samples were analyzed using a graphite furnace atomic 
absorption spectrometer (AAnalyst 800, Perkin Elmer, Shelton, CT). 
Graphite Furnace Atomic Absorption Spectrometer Parameters 
Instrument Control Method 
Instrument Name: AAnalyst 800 
Instrument Type: PE Atomic Absorption Spectrometer 
Lamp Parameters 
Element: Iron 
Lamp Type: C-Hollow Cathode Lamp (HCL) 
Slit Width (nm): 0.2L 
Desired Current (mA): 47 
Wavelength (nm): 248.3 
Signal Type: AA-BG 
Measurement: Peak Area 
Furnace Program 
Injection Temperature (°C): 50 
Step One 
Temperature (°C): 50 - 130 
Ramp Time (sec): 5 
Hold Time (sec): 30 . 
Internal Flow (mL/min): 250 
Gas Type: Normal 
Step Two 
Temperature (°C): 130 - 1400 
Ramp Time (sec): 15 
Hold Time (sec): 20 
Internal Flow (mL/min): 250 
Gas Type: Normal 
Step Three* 
Temperature (°C): 1400 - 2100 
Ramp Time (sec): 0 
Hold Time (sec): 5 
Internal Flow (mL/min): 0 
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Gas Type: Normal 
* atomization stage during which results were recorded 
Step Four 
Temperature (°C): 2100 - 2450 
Ramp Time (sec): 1 
Hold Time (sec): 5 
Internal Flow (mL/min): 250 
Gas Type: Normal 
Extra Furnace Cleanout: Yes 
Furnace Autosampler 
Sample Volume (µL): 5 
Matrix Modifier #1 Volume (µL): 20 
Add to Calibration Blank and Standards: Yes 
Add to Reagent Blank and Samples: Yes 
Matrix Modifier #1 Location: 142 
Autosampler and Furnace Sequence 
Step A: Pipet Modifier! + Sample/Std 
Step B: Run Furnace Steps 1 to end 
Pipet Speed(%): 100 
Dispensing Speed(%): 100 
Calibration Equation 
Equation: Linear, Calculated Intercept 
Calibration Units: mg/g 
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Sample Units: mg/g 
Replicates: 2 for each sample/standard 
Standard Concentrations 
Calibration Blank: Matrix Modifier 
Calibration Blank A/S Location: 1 
Stock Volume (µL): 5 
Matrix Modifer Volume (µL): 20 
Standard One: 0.010 mg/g Iron 
Standard One Concentration (mg/g): 0.010 
Standard One A/S Location: 2 
Stock Volume (µL): 5 
Matrix Modifer Volume (µL) : 20 
Standard Two: 0.025 mg/g Iron 
Standard Two Concentration (mg/g): 0.025 
Standard Two A/S Location: 3 
Stock Volume (µL): 5 
Matrix Modifer Volume (µL): 20 
Standard Three: 0.050 mg/g Iron 
Standard Three Concentration (mg/g): 6.050 
Standard Three A/S Location: 4 
Stock Volume (µL): 5 
Matrix Modifer Volume (µL): 20 
Standard Four: 0.100 mg/g Iron 
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Standard Four Concentration (mg/g): 0.100 
Standard Four A/S Location:, 5 
Stock Volume (µL) : 5 
Matrix Modifer Volume (µL): 20 
Standard Five: 0.250 mg/g Iron 
Standard Five Concentration (mg/g): 0.250 
Standard Three A/S Location: 6 
Stock Volume (µL): 5 
Matrix Modifer Volume (µL): 20 
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CHAPTER IV 
DATA AND RESULTS 
Ten tablets from each brand were randomly selected and used for this research. 
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Each of the 80 samples were weighed out and had 1/8 total tablet weight collected. Ten 
mL of2% nitric acid solution were added to each sample. Once vortexed for five to seven 
seconds and centrifuged at 3,000 rpm for 40 minutes, each sample had 10.00 µL 
withdrawn and placed in new, separate test tubes. Each test tub~ containing the 10.00 µL 
of sample had 10.00 mL of the 0.253 mg/g magnesium nitrate matrix modifier added. 
Again, all samples were vortexed for five to seven seconds, one mL from each sample 
was placed in a new test tube. Test tubes containing 1.00 mL of sample then had 1.00 mL 
of magnesium nitrate matrix modifier added. All samples were then vortexed for five 
seconds. The 80 samples that contained a total volume of two mL were used for analysis. 
Numerous dilutions were necessary due to the sensitivity of the instrumentation used. 
Each standard was made by placing 10.00 mL 2% nitric acid solution into clean, 
separate test tubes. Iron standards were created using the 1,000 mg/L stock iron standard . 
in concentrations of 0.010, 0.025, 0.050, 0.100, and 0.250 mg/g respectively. Each 
standard was then vortexed for approximately five seconds. After being vortexed, 10.00 
µL of each standard was withdrawn and placed in new, separate test tubes. With each test 
tube containing the 10.00 µL of standard, 10.00 mL of the 0.253 mg/g magnesium nitrate 
matrix modifier was added. The samples were then vortexed for five seconds. After 
vortexing, 1.00 mL of each test tube was added to a new, separate test tube. In each test 
tube containing the 1.00 mL of standard, 1.00 mL of the 0.253 mg/g magnesium nitrate 
matrix modifier was added and then vortexed for five seconds. The standards and 
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samples were then analyzed by the graphite furnace atomic absorption spectrometer and 
quantitated for iron concentration. 
Each sample's iron concentration was determined by comparing the individual 
sample' s absorbance signal, peak area, and peak height to the absorbance signal, peak 
area, and peak height of the standards created. Each standard 's absorbance signal, peak 
area, and peak height were used to build a calibration curve so samples' absorbance 
signals, peak areas, peak heights, and iron concentrations could be plotted and quantified. 
The calibration curve from the iron standards are given in Figure 1. The concentrations of 
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conc(mg/g) 0 .250 
Calib Eq'n : Lin. Cale Int 
Corr Coeff: 0 .9971 82 
Figure 1. Iron Calibration Curve. The calibration curve was created by plotting the 
concentrations of the iron standards of 0.010, 0.025, 0.050, 0.100, and 0.250 mg/g 
respectively against the absorbance values produced. 
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Table 1 
Standards of Iron Concentrations and Absorbance Values 
Standard No. Standard ID Absorbance 
Entered Cone. Calculated 
Signal (mg/g) Cone. (mg/g) 
Blank Matrix 0.0000 0.000 0.003 Modifier 
1 Std. One 0.0126 0.010 0.012 
2 Std. Two 0.0302 0.025 0.025 
3 Std. Three 0.0693 0.050 0.054 
4 Std. Four 0.1127 0.100 0.086 
5 Std. Five 0.3421 0.250 0.255 
Iron concentrations and absorbance values obtained from iron standards of concentrations of 0.0 I 0, 0.025, 0.050, 0.100, and 0.250 
mg/g respectively. 
Table 2 
Name brand A 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.3240 18.00 12.4723 
1 2 0.3290 18.00 12.5523 
2 1 0.4210 18.00 13.9388 
2 2 0.4210 18.00 13.9388 
3 1 0.3830 18.00 13.9314 
3 2 0.3680 18.00 13.6914 
4 1 0.4300 18.00 14.6765 
4 2 0.4290 18.00 14.6605 
5 1 0.6070 18.00 . 17.0460 
5 2 0.6170 18.00 17.2060 
6 1 0.5400 18.00 15.9435 
6 2 0.5290 18.00 15.7675 
7 1 0.5710 18.00 16.9035 
7 2 0.5690 18.00 16.8715 
8 1 0.7080 18.00 18.8738 
8 2 0.7060 18.00 18.8418 
































Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Name brand A. 
Table 3 
Name brand B 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.9220 18.00 18.9229 
1 2 0.9390 18.00 19.1949 
2 1 0.9590 18.00 19.2175 
2 2 0.9050 18.00 18.3535 
3 1 1.0330 18.00 20.7919 
3 2 1.0020 18.00 20.2957 
4 1 0.9780 18.00 19.9348 
4 2 0.9700 18.00 19.8068 
5 1 0.6880 18.00 15.1373 
5 2 0.7440 18.00 16.0333 
6 1 0.7820 18.00 16.6807 
6 2 0.7890 18.00 16.7927 
7 1 0.7490 18.00 16.0529 
7 2 0.7390 18.00 15.8997 
8 1 0.8270 18.00 17.6676 
8 2 0.8180 18.00 17.5236 
9 1 0.7300 18.00 16.0261 
9 2 0.7310 18.00 16.0421 
10 1 0.7730 18.00 16.4984 
10 2 0.7700 18.00 16.4505 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Name brand B. 
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Table 4 
Name brand C's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.2070 6.00 4.7083 
1 2 0.1940 6.00 4.5003 
2 1 0.3310 6.00 6.7615 
2 2 0.3330 6.00 6.7935 
3 1 0.3370 6.00 6.9857 
3 2 0.3390 6.00 7.0177 
4 1 0.2980 6.00 6.2390 
4 2 0.2940 6.00 6.1750 
5 1 0.2950 6.00 6.1714 
5 2 0.3100 6.00 6.4114 
6 1 0.3000 6.00 6.2425 
6 2 0.3060 6.00 6.3385 
7 1 0.3370 6.00 6.8414 
7 2 0.3310 6.00 6.7454 
8 1 0.2790 6.00 6.0645 
8 2 0.2790 6.00 6.0645 
9 1 0.3090 6.00 6.4300 
9 2 0.3030 6.00 6.3340 
10 1 0.2450 6.00 5.3276 
10 2 0.2380 6.00 5.2156 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Name brand C. 
Table 5 
Name brand D 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.2920 5.00 5.8668 
1 2 0.2830 5.00 5.7228 
2 1 0.2740 5.00 5.5301 
2 2 0.2730 5.00 5.5141 
3 1 0.2740 5.00 5.5209 
3 2 0.2710 5.00 5.4729 
4 1 0.1550 5.00 3.4652 
4 2 0.1570 5.00 3.4972 
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Table 5 ( continued). 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
5 1 0.3210 5.00 6.3250 
5 2 0.2750 5.00 5.5890 
6 1 0.2210 5.00 5.1685 
6 2 0.2260 5.00 5.2485 
7 1 0.2040 5.00 4.9020 
7 2 0.1980 5.00 4.8060 
8 1 0.2590 5.00 5.1437 
8 2 0.2600 5.00 5.1597 
9 1 0.2390 5.00 4.8195 
9 2 0.2370 5.00 4.7875 
10 1 0.2990 5.00 5.9393 
10 2 0.2980 5.00 5.9233 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Name brand D. 
Table 6 
Generic E 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.6750 18.00 17.2222 
1 2 0.6740 18.00 17.2062 
2 1 0.5680 18.00 15.3906 
2 2 0.5640 18.00 15.3266 
3 1 0.7240 18.00 17.8400 
3 2 0.7300 18.00 17.9360 
4 1 0.1950 18.00 9.5063 
4 2 0.2720 18.00 10.7383 
5 1 0.1480 18.00 8.4609 
5 2 0.1450 18.00 8.4129 
6 1 0.1740 18.00 9.1763 
6 2 0.1660 18.00 9.0483 
7 1 0.1810 18.00 9.1673 
7 2 0.1500 18.00 8.6713 
8 1 0.1380 18.00 8.3939 
8 2 0.1310 18.00 8.2819 
9 1 0.1490 18.00 8.6101 
9 2 0.1480 18.00 8.5941 
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Table 6 ( continued). 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
10 1 0.1230 18.00 8.3296 
10 2 0.1300 18.00 8.4416 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Generic E. 
Table 7 
Generic F 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.0170 18.00 5.6934 
1 2 0.0160 18.00 5.6774 
2 1 0.5500 18.00 13.9208 
2 2 0.5530 18.00 13.9688 
3 1 0.3300 18.00 10.7583 
3 2 0.3290 18.00 10.7423 
4 1 0.3830 18.00 11.4528 
4 2 0.3770 18.00 11.3568 
5 1 0.2760 18.00 9.7613 
5 2 0.2740 18.00 9.7293 
6 1 0.4340 18.00 12.1572 
6 2 0.4370 18.00 12.2052 
7 1 0.7110 18.00 16.5946 
7 2 0.6940 18.00 16.3226 
8 1 0.8760 18.00 19.3382 
8 2 0.8850 18.00 19.4822 
9 1 0.6520 18.00 15.2355 
9 2 0.6420 18.00 . 15.0755 
10 1 0.3240 18.00 10.5400 
10 2 0.3320 18.00 10.6680 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Generic F. 
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Table 8 
Generic G 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.6200 15.0000 9.9200 
1 2 0.6240 15.0000 9.9840 
2 1 0.5650 15.0000 9.0400 
2 2 0.5590 15.0000 8.9440 
3 1 0.5780 15.0000 9.2480 
3 2 0.5670 15.0000 9.0720 
4 1 0.5130 15.0000 8.2080 
4 2 0.5130 15.0000 8.2080 
5 1 0.5260 15.0000 8.4160 
5 2 0.5280 15.0000 8.4480 
6 1 0.6210 15.0000 9.9360 
6 2 0.5970 15.0000 9.5520 
7 1 0.6060 15.0000 9.6960 
7 2 0.6090 15.0000 9.7440 
8 1 0.8690 15.0000 13.9040 
8 2 0.8760 15.0000 14.0160 
9 1 0.6960 15.0000 11.1360 
9 2 0.7050 15.0000 11.2800 
10 1 0.8200 15.0000 13.1200 
10 2 0.8120 15.0000 12.9920 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Generic G. 
Table 9 
Generic H 's Iron Concentrations 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
1 1 0.4470 18.00 11.9303 
1 2 0.4600 18.00 12.1383 
2 1 0.3860 18.00 11.2077 
2 2 0.3780 18.00 11.0797 
3 1 0.4840 18.00 12.8914 
3 2 0.5510 18.00 13.9634 
4 1 0.3450 18.00 10.8296 
4 2 0.3430 18.00 10.7976 
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Table 9 ( continued). 
Sample Replicate Sample Cone. Expected Tablet Total Tablet Sample 
No. No. (mg/g) Cone. (mg) Cone. (mg) 
5 1 0.6410 18.00 15.5217 
5 2 0.0646 18.00 6.2993 
6 1 0.5090 18.00 13.3835 
6 2 0.5060 18.00 13.3355 
7 1 0.7070 18.00 16.3428 
7 2 0.7080 18.00 16.3588 
8 1 0.5680 18.00 14.3220 
8 2 0.5660 18.00 14.2900 
9 1 0.4760 18.00 12.8771 
9 2 0.4700 18.00 12.7811 
10 1 0.3210 18.00 10.5177 
10 2 0.3210 18.00 10.5177 
Iron Sample Concentrations, Expected Tablet Concentration, and Total Actual Concentration for Generic H. 
In order to compare the variance of iron concentrations among brands, the 
coefficient of relative variation was determined for each brand and then compared to the 
other brands. Due to the brands being of different sizes and different concentrations, the 
coefficient of relative variation allows the different brands to be compared on a 
standardized level. The data shows us that the name brands A-D have a relatively small 
coefficient of relative variance, which determines that there is a small amount of variation 
between the vitamins within their own brand. The generic vitamins E-H have a large 
coefficient of relative variances; this establishes that, within the generic brands tested, the 
samples are not precise. The difference between the mean concentration obtained from 
the instrumentation for name brands A-D and the expected concentration for name brands 
A-Dare extremely small, which shows that the concentration stated on the labels for the 
name brand vitamins are within acceptable concentration for the actual tablets. For the 
generic E-H vitamins, the difference between actual tablet concentration and expected 
tablet concentrations vary greatly. The data shows that the generic brands E-H tablets 
contain four to six milligrams less than what is described on the label (Table 10). The 
probability of error or statistical difference cannot be determined due to small sample 
sizes for each brand. 
Table 10 
Comparison of All Brands ' Descriptive Statistics 
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Vitamin Exp. Cone. Mean Cone. Std. CRV Difference of Cones. (mg/g) (mg/g) Dev. (%) (mg/g) 
NBrand 15.00 15.8347 1.93 12.16 0.8347 A 
NBrand 18.00 17.6665 1.70 9.63 -0.3335 B 
NBrand 6.00 6.1584 0.70 11.27 0.1584 C 
NBrand 5.00 5.2201 0.71 13.58 0.2201 D 
Generic 18.00 11.2377 3.74 33.28 -6.7623 E 
Generic 18.00 12.534 3.67 29.27 -5.4660 F 
Generic 15.00 10.2432 1.83 17.87 -4.7568 G 
Generic 18.00 12.5693 2.30 18.26 -5.4307 H 
Expected Concentration, Mean Concentration, Standard Deviation, Coefficent of Relative Variance, and Difference of Concentrations 




Iron is a metal that is found naturally on this earth; it is in the air, the soil, and the 
water. While iron is important to the environment, it plays an even more crucial role in 
the human body. Papanikolauo and Pantopoulos (2005) describe iron as " indispensable 
for life" (p. 199). Iron not only transports oxygen from the lungs to the muscles via red 
blood cells, but it also plays a role in electron transfer reactions, cell survival, and the 
stabilization of DNA and RNA (Papanikolauo & Pantopoulos, 2005). For humans, most 
iron is located in the red blood cells as hemoglobin, which is what is responsible for 
sending oxygen to the oxygen-deprived cells and tissues of the body (Sheftel, Mason, & 
Ponka, 2012). 
Children need iron when they are young because iron helps in the growth and 
development of cells, bones, and the brain. However, because children are still growing, 
the amount of iron needs to be carefully monitored. Iron deficiency is common in 
children who are finicky eaters or have a less than balanced diet; most parents correct the 
mineral deficiency by giving the child a multivitamin. Concentrations of the mineral are 
usually 100% of the recommended value but, if given too many, can cause toxicity when 
too much is taken. Name brand vitamins are assumed to be of good quality and are 
favored among children and adults; the disadvantage to name brand vitamins is that they 
can be costly. Generic vitamins are often assumed to contain the same concentrations as 
name brand vitamins yet cost less. Disadvantages to generic vitamins are that they may 
not be made with the same quality as name brand products, thus resulting in less 
concentrated tablets and/or unfavorable taste for children. 
34 
In this study, eight brands of children's multivitamins that contained iron were 
collected; out of the eight brands, four brands were name brand vitamins and the other 
four brands were generic vitamins. To reasonably represent each brand, 10 vitamins from 
each brand were randomly selected to be tested for iron concentration. Through a process 
of weighing out each vitamin and diluting each sample with the appropriate amounts .2% 
nitric acid solution and 0.253 mg/g magnesium sulfate matrix modifier, concentrations of 
iron were obtained via analyses with a graphite furnace atomic absorption spectrometer. 
Through the results, the name brand A-D vitamins showed small variance among their 
own particular brand and showed extremely small differences between the actual 
concentration and the stated concentration; the generic brand E-H vitamins showed that 
there was a large dispersion among the vitamins in each brand and had large differences 
between the actual concentration and the stated concentrations. It can be concluded that, 
while generic vitamins do cost less, the quality of the vitamins, particularly in iron 
concentration, is poor compared to the name brand vitamins' quality. 
This study can be beneficial to parents who are trying to decide which type of 
vitamin, generic or name brand, would be best for their child and which is the most 
effective brand, both for cost and desired result. This study can also help companies who 
design the generic vitamins by pointing out that the quality is not up to industry 
standards. Future research could use this study to perform similar testing with 
multivitamins with other mineral concentrations to determine if there are correlations or 
differences between the two types of children's multivitamins. 
1. Project Goals: 
APPENDIX A 
RESEARCH PROTOCOL 
To compare stated iron concentrations in both name brand and generic children's 
multivitamins to concentrations found. 
2. Protocols: 
Samples to be collected: 
• Samples were randomly selected from each brand of children' s multivitamins 
purchased for the experiment. 
Brief Experimental Procedure: 
• Samples will be weighed and ground into a fine powder and one-eighth of each 
sample will be used. 
• 10.00 mL of 0.2% nitric acid is added to each sample, then vortexed and 
centrifuged. 
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• Through a series of dilutions, along with the addition of a magnesium nitrate 
matrix modifier, the samples will become diluted enough for the sensitivity of the 
instrument. 
• Samples will be run through the graphite furnace atomic absorption spectrometer 
for analysis. 
Research Locations: 
• Research and result analysis was conducted in the Forensic Chemistry 
Laboratory, School of Criminal Justice, The University of Southern Mississippi. 
4. Risks: 
Anonymity: 
• All information regarding specific companies ' brands will be replaced with 
different titles, either Name brand X or Generic X. 
5. Informed Consent: 
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